Dose of imatinib mesylate. Medical search. Frequent questions

Home page Questions and answers Statistics Donations Contact

Anatomy17

K562 Cells Philadelphia Chromosome Cell Line, Tumor Chromosomes, Human, Pair 9 Neoplastic Stem Cells Myeloid Progenitor Cells Cells, Cultured Bone Marrow Orbit Skin Hematopoietic Stem Cells HL-60 Cells Stromal Cells Tumor Cells, Cultured Fibroblasts Bone Marrow Cells Cell Line

Organisms4

Mice, SCID Mice, Nude Mice, Inbred BALB C Mice, Inbred NOD

Diseases41

Leukemia, Myelogenous, Chronic, BCR-ABL Positive Gastrointestinal Stromal Tumors Leukemia, Myeloid, Chronic-Phase Blast Crisis Hypereosinophilic Syndrome Hypopigmentation Gastrointestinal Neoplasms Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative Philadelphia Chromosome Dermatofibrosarcoma Mastocytosis, Systemic Fibromatosis, Aggressive Leukemia, Myeloid, Accelerated Phase Lichenoid Eruptions Neoplasm, Residual Disease Progression Primary Myelofibrosis Recurrence Precursor Cell Lymphoblastic Leukemia-Lymphoma Scleroderma, Systemic Histiocytoma, Malignant Fibrous Fibrosis Graves Ophthalmopathy Spinal Cord Neoplasms Leukemia Neutropenia Chromosome Aberrations Pulmonary Fibrosis Bone Neoplasms Nerve Sheath Neoplasms Peritoneal Neoplasms Neoplasm Recurrence, Local Neoplasms Brain Neoplasms Myeloproliferative Disorders Neoplasm Metastasis Skin Neoplasms Disease Models, Animal Nausea Osteosarcoma Melanoma

Chemicals and Drugs54

Benzamides Piperazines Pyrimidines Fusion Proteins, bcr-abl Antineoplastic Agents Proto-Oncogene Proteins c-kit Protein Kinase Inhibitors Receptor, Platelet-Derived Growth Factor alpha Receptor, Platelet-Derived Growth Factor beta Proto-Oncogene Proteins c-abl Protein-Tyrosine Kinases Receptors, Platelet-Derived Growth Factor Enzyme Inhibitors Pregnatrienes Thiazoles Proto-Oncogene Proteins c-sis Harringtonines Interferon-alpha mRNA Cleavage and Polyadenylation Factors Ketones Pyrroles Furans Rifabutin Hydroxyurea Platelet-Derived Growth Factor STAT5 Transcription Factor Stem Cell Factor RNA, Messenger Indoles Oncogene Proteins, Fusion Antigens, CD34 Milk Proteins Cytarabine Neoplasm Proteins src-Family Kinases P-Glycoprotein Lactams, Macrocyclic ATP-Binding Cassette Transporters Benzoquinones Pyridines Bleomycin Deferoxamine Ergoloid Mesylates Tumor Markers, Biological Proto-Oncogene Proteins c-akt Organic Cation Transporter 1 Mesylates Deoxycytidine Fluorodeoxyglucose F18 Pergolide Receptors, Granulocyte Colony-Stimulating Factor Fenoldopam Pefloxacin Benzoxazines

Analytical, Diagnostic and Therapeutic Techniques and Equipment43

Cytogenetic Analysis Treatment Outcome Remission Induction Drug Approval Administration, Oral Disease-Free Survival Drug Administration Schedule Antineoplastic Combined Chemotherapy Protocols Survival Analysis Treatment Failure Prognosis Salvage Therapy Survival Rate Reverse Transcriptase Polymerase Chain Reaction In Situ Hybridization, Fluorescence Follow-Up Studies Inhibitory Concentration 50 Combined Modality Therapy Blood Cell Count Immunohistochemistry Neoadjuvant Therapy Transplantation, Homologous Blotting, Western Drug Screening Assays, Antitumor Hematopoietic Stem Cell Transplantation DNA Mutational Analysis Clinical Trials as Topic Positron-Emission Tomography Xenograft Model Antitumor Assays Retrospective Studies Kaplan-Meier Estimate Karyotyping Tomography, X-Ray Computed Disease Models, Animal Polymerase Chain Reaction Prospective Studies Radiation Dosage Area Under Curve Lethal Dose 50 Flow Cytometry Gene Expression Profiling Double-Blind Method Oligonucleotide Array Sequence Analysis

Phenomena and Processes28

Drug Resistance, Neoplasm Genes, abl Philadelphia Chromosome Dose-Response Relationship, Drug Apoptosis Time Factors Cell Proliferation Drug Synergism Phosphorylation Mutation Gene Expression Regulation, Leukemic Chromosomes, Human, Pair 9 Inhibitory Concentration 50 Signal Transduction Cell Survival Blood Cell Count Cell Division G0 Phase Chromosome Aberrations Gene Expression Regulation, Neoplastic Down-Regulation Point Mutation Drug Interactions Radiation Dosage Area Under Curve Lethal Dose 50 Gene Expression Cell Cycle

Disciplines and Occupations2

Cytogenetics Immunohistochemistry

Anthropology, Education, Sociology and Social Phenomena2

Drug Approval United States Food and Drug Administration

Technology, Industry, Agriculture1

Information Science1

Health Care14

Treatment Outcome Disease-Free Survival Survival Analysis Treatment Failure United States Food and Drug Administration Survival Rate Follow-Up Studies Clinical Trials as Topic Retrospective Studies Kaplan-Meier Estimate Prospective Studies Radiation Dosage Area Under Curve Double-Blind Method

Anatomy Organisms Diseases Chemicals and Drugs Analytical, Diagnostic and Therapeutic Techniques and Equipment Phenomena and Processes Disciplines and Occupations Anthropology, Education, Sociology and Social Phenomena Technology, Industry, Agriculture Information Science Health Care

Benzamides Piperazines Pyrimidines Leukemia, Myelogenous, Chronic, BCR-ABL Positive Gastrointestinal Stromal Tumors Fusion Proteins, bcr-abl Antineoplastic Agents Proto-Oncogene Proteins c-kit Protein Kinase Inhibitors Receptor, Platelet-Derived Growth Factor alpha Leukemia, Myeloid, Chronic-Phase Receptor, Platelet-Derived Growth Factor beta Blast Crisis Drug Resistance, Neoplasm Hypereosinophilic Syndrome Genes, abl Cytogenetic Analysis Proto-Oncogene Proteins c-abl Protein-Tyrosine Kinases Hypopigmentation K562 Cells Gastrointestinal Neoplasms Treatment Outcome Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative Philadelphia Chromosome Remission Induction Receptors, Platelet-Derived Growth Factor Dermatofibrosarcoma Mastocytosis, Systemic Enzyme Inhibitors Drug Approval Pregnatrienes Cell Line, Tumor Thiazoles Administration, Oral Fibromatosis, Aggressive Dose-Response Relationship, Drug Proto-Oncogene Proteins c-sis Disease-Free Survival Harringtonines Leukemia, Myeloid, Accelerated Phase Drug Administration Schedule Apoptosis Time Factors Cell Proliferation Interferon-alpha Lichenoid Eruptions Drug Synergism mRNA Cleavage and Polyadenylation Factors Phosphorylation Antineoplastic Combined Chemotherapy Protocols Neoplasm, Residual Mutation Survival Analysis Ketones Pyrroles Furans Gene Expression Regulation, Leukemic Treatment Failure Cytogenetics Prognosis United States Food and Drug Administration Salvage Therapy Rifabutin Disease Progression Primary Myelofibrosis Survival Rate Reverse Transcriptase Polymerase Chain Reaction Recurrence Chromosomes, Human, Pair 9 Hydroxyurea In Situ Hybridization, Fluorescence Neoplastic Stem Cells Platelet-Derived Growth Factor STAT5 Transcription Factor Follow-Up Studies Precursor Cell Lymphoblastic Leukemia-Lymphoma Scleroderma, Systemic Inhibitory Concentration 50 Stem Cell Factor Signal Transduction Histiocytoma, Malignant Fibrous RNA, Messenger Indoles Cell Survival Combined Modality Therapy Myeloid Progenitor Cells Blood Cell Count Fibrosis Immunohistochemistry Cells, Cultured Neoadjuvant Therapy Graves Ophthalmopathy Oncogene Proteins, Fusion Bone Marrow Antigens, CD34 Transplantation, Homologous Blotting, Western Milk Proteins Cytarabine

No FAQ available that match "dose of imatinib mesylate"